DAWN icon

Day One Biopharmaceuticals

108 hedge funds and large institutions have $1.29B invested in Day One Biopharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 39 increasing their positions, 25 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

more capital invested

Capital invested by funds: $ → $

0.88% less ownership

Funds ownership: 82.72%81.84% (-0.88%)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

33% less call options, than puts

Call options by funds: $2.98M | Put options by funds: $4.43M

Holders
108
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.98M
Puts
$4.43M
Net Calls
Net Calls Change

Top Sellers

1 -$95M
2 -$12.9M
3 -$8.01M
4
BlackRock
BlackRock
New York
-$2.28M
5
CSS
Cubist Systematic Strategies
Connecticut
-$1.77M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$194M
2
$163M
3
$152M
4
$71M
5
$66.9M
6
$54.8M
7
$53.2M
8
$52.9M
9
$52.4M
10
$47M
11
$38M
12
$33.5M
13
$30.1M
14
$26.8M
15
$25.6M
16
$21.4M
17
$20.7M
18
$16.9M
19
$15.9M
20
$12.9M
21
$12.5M
22
$11.7M
23
$10.9M
24
$10.4M
25
$9.93M